Objective: The aim of this study was to explore the efficacy of percutaneous coronary intervention (PCI) with minimally invasive direct coronary artery bypass grafting (MIDCABG) in the treatment for multivessel coronary artery disease (CAD). Methods: Clinical data was collected from 208 patients with multivessel CAD involving left anterior descending coronary artery (LAD) who underwent PCI between January 2012 and January 2014. There were 16 patients undergoing two-stage hybrid coronary revascularization (HCR) and another 16 paired patients undergoing PCI alone as control. All the patients in HCR group underwent MIDCABG and 3-7 days antiplatelet therapy followed by PCI. Results: No death and severe complications were observed in 16 patients undergoing HCR, who had longer hospital stay (11.88 ± 1.15 vs 7.19 ± 1.11 days) and higher medical expense (103186.16 ± 8743.86 vs 64645.66 ± 4929.50 yuan) compared with PCI group.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.